Cranial Nerve Stimulation for Diverse Health and Performance Applications

The inventive concept expands the original patent's cranial nerve stimulation technology to novel applications in athletic performance, cognitive function, pain modulation, speech clarity, and inflammation reduction, offering new opportunities for improving human health and well-being.

The original patent focused on treating sleep disorders and breathing disorders. However, the limitations of the original patent did not explore the full potential of cranial nerve stimulation in other areas. The new inventive concept addresses this gap by applying the core technology to diverse health and performance applications, providing innovative solutions to previously unaddressed problems.

The new inventive concept comprises a neuromodulation device configured to stimulate specific cranial nerves associated with various physiological functions. For instance, Claim 1 describes a system for optimizing athletic performance by stimulating a cranial nerve associated with respiratory function. Claim 2 outlines a method for enhancing cognitive function in individuals with ADHD by stimulating a cranial nerve target associated with attention and focus. Similarly, Claims 3-5 describe devices and methods for treating migraines, improving speech clarity in individuals with Parkinson's disease, and reducing chronic inflammation in individuals with rheumatoid arthritis. These new applications leverage the original patent's technology to provide novel solutions for unmet medical needs and performance enhancement.

The new claims introduce novel and non-obvious applications of cranial nerve stimulation, departing from the original patent's focus on sleep disorders and breathing disorders. The inventive step lies in recognizing the potential of this technology to address a broader range of health and performance challenges, and designing specific implementations to achieve these new goals.

Alternative embodiments of the inventive concept could include miniaturized or implantable devices, wearable sensors, or personalized neuromodulation signal generation algorithms. Variations could involve adapting the technology for use in veterinary medicine, or developing new neuromodulation signal protocols for specific applications.

The inventive concept has significant commercial potential in various industries, including sports medicine, neurology, pain management, and pharmaceuticals. The target market includes athletes, individuals with ADHD, migraine sufferers, individuals with Parkinson's disease, and those with rheumatoid arthritis, among others. The technology could be licensed to companies operating in these spaces or developed into proprietary products.